Correction: Group-by-Treatment Interaction Effects in Comparative Bioavailability Studies

AAPS J. 2024 May 6;26(3):58. doi: 10.1208/s12248-024-00927-5.

Helmut Schütz^{1

2

3}, Divan A Burger^{4

5}, Erik Cobo⁶, David D Dubins⁷, Tibor Farkás⁸, Detlew Labes⁹, Benjamin Lang¹⁰, Jordi Ocaña¹¹, Arne Ring^{12

13}, Anastasia Shitova¹⁴, Volodymyr Stus¹⁵, Michael Tomashevskiy¹⁶

¹ Center for Medical Data Science of the Medical University of Vienna, 1090, Vienna, Austria. helmut.schuetz@bebac.at.
² Faculty of Pharmacy, Universidade de Lisboa, 1649-004, Lisbon, Portugal. helmut.schuetz@bebac.at.
³ BEBAC, Neubaugasse 36/11, 1070, Vienna, Austria. helmut.schuetz@bebac.at.
⁴ University of Pretoria, Pretoria, South Africa.
⁵ Syneos Health, Bloemfontein, South Africa.
⁶ Department of Statistics and Operations Research, Universitat Politecnica de Catalunya, Barcelona, Catalunya, Spain.
⁷ Leslie Dan Faculty of Pharmacy, Toronto, Ontario, Canada.
⁸ Gedeon Richter Plc, Budapest, Hungary.
⁹ , Berlin, Germany.
¹⁰ Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
¹¹ Department of Genetics, Microbiology and Statistics, Universitat de Barcelona, Barcelona, Catalunya, Spain.
¹² Hexal - a Sandoz Brand, Holzkirchen, Germany.
¹³ University of the Free State, Bloemfontein, South Africa.
¹⁴ Quinta-Analytica Yaroslavl, Yaroslavl, Russian Federation.
¹⁵ Zakłady Farmaceutyczne Polpharma S.A, Starogard Gdanski, Poland.
¹⁶ OnTarget Group, Saint Petersburg, Russian Federation.

No abstract available

Publication types